Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

JPH posts net income of $4.19 million in 9M 2018

2018-11-04

According to the financial statements of Jerusalem Pharmaceuticals JPH for the first nine months of 2018, Net profit after tax of the period reached 4,196,241 USD Compared with Net profit after tax 4,301,803 USD for 2017, a net decrease in profit of 2.45%.Total assets of the company reached 60,742,407 USD compared with total assets of 61,625,755 USD at the end of year 2017, a net decrease of 1.43%.Total liabilities of the company reached 11,710,802 USD compared with total liabilities of 12,237,751 USD at the end of year 2017, a net decrease of 4.30%. Net ownership equity of the company reached 49,031,605 USD (Including Non-Controlling Interests of 835,695 USD) compared with total owner equity of 49,388,004 USD (Including Non-Controlling Interests of 851,077 USD) at the end of year 2017, a net decrease of 0.72%.

 


 

2021-04-08
QUDS approves distributing 3.50% stocks dividends and 4.50% cash dividends for the year 2020

2021-04-08
TRUST approves distributing 10% cash dividends for the year 2020

2021-04-08
Relative Calmness in the PEX and a momentum in holding the general assembly meetings

2021-04-08
NCI proposes distributing 10% cash dividends for the year 2020

2021-04-08
PEC approves distributing 10% cash dividends for the year 2020

2021-04-04
NIC approves distributing 15% stocks dividends and 22.5% cash dividends for the year 2020

2021-04-01
APIC proposes distributing 9.1476% stocks dividends and 7.50% cash dividends for the year 2020

2021-04-01
Al-Quds Index declines significantly following the dividends’ entitlement of the PEX’s two largest companies

2021-04-01
BOP approves distributing 1% stocks dividends and 4% cash dividends for the year 2020

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013